CIK 0001665988 · Accelerated filer<br>Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 810980861
- Phone
- (919) 474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- 4 Option exercise President and CEO acquired 93,750 shares (option exercise)
- 8-K Event Acquisition or sale completed · Other events
- 4 Planned sale SVP & CFO sold 10,733 shares at $10.53 ($113,018)
- 4 Planned sale SVP & Chief Compliance Officer sold 2,535 shares at $10.53 ($26,694)
- 4 Planned sale SVP & General Counsel sold 5,848 shares at $10.53 ($61,579)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Option exercise SVP & CFO acquired 31,000 shares (option exercise)
- 4 Option exercise SVP & Chief Compliance Officer acquired 8,600 shares (option exercise)
- 4 Option exercise SVP & General Counsel acquired 19,850 shares (option exercise)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3 Offering Registration Statement
Page 6 of 24 · 463 filings